For example, in treating patients with Fanconi anemia (FA), NHEJ-mediated gene editing was employed to efficiently edit multiple FANCA mutations in long-term hematopoietic stem cells (HSCs) and lymphoblastic cell lines (LCLs) 186. This evidence concerns the gene FANCA and Friedreich ataxia.